These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30670084)

  • 1. Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies.
    de Souza FHC; de Araújo DB; Vilela VS; Bezerra MC; Simões RS; Bernardo WM; Miossi R; da Cunha BM; Shinjo SK
    Adv Rheumatol; 2019 Jan; 59(1):6. PubMed ID: 30670084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brazilian Society of Rheumatology recommendations on investigation and diagnosis of systemic autoimmune myopathies.
    de Souza FHC; de Araújo DB; Vilela VS; Simões RS; Bernardo WM; Frank TA; da Cunha BM; Shinjo SK
    Adv Rheumatol; 2019 Oct; 59(1):42. PubMed ID: 31601261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series.
    Olivo Pallo PA; de Souza FHC; Miossi R; Shinjo SK
    Adv Rheumatol; 2018 Oct; 58(1):34. PubMed ID: 30657093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
    Vermaak E; Tansley SL; McHugh NJ
    Clin Rheumatol; 2015 Dec; 34(12):2089-95. PubMed ID: 26299472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of inflammatory myopathies.
    Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2018 Jul; 14(7):607-621. PubMed ID: 29952659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on therapy for refractory dermatomyositis and polymyositis.
    Villalba L; Adams EM
    Curr Opin Rheumatol; 1996 Nov; 8(6):544-51. PubMed ID: 9018458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic approaches for polymyositis and dermatomyositis].
    Dankó K; Vincze M
    Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus-based recommendations for the management of juvenile dermatomyositis.
    Bellutti Enders F; Bader-Meunier B; Baildam E; Constantin T; Dolezalova P; Feldman BM; Lahdenne P; Magnusson B; Nistala K; Ozen S; Pilkington C; Ravelli A; Russo R; Uziel Y; van Brussel M; van der Net J; Vastert S; Wedderburn LR; Wulffraat N; McCann LJ; van Royen-Kerkhof A
    Ann Rheum Dis; 2017 Feb; 76(2):329-340. PubMed ID: 27515057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes].
    Göttfried I; Seeber A; Anegg B; Pirkhammer D; Rieger A; Stingl G; Volc-Platzer B
    Wien Klin Wochenschr; 1996 Nov; 108(22):705-16. PubMed ID: 9157716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of autoimmune inflammatory myopathies.
    Mastaglia FL
    Curr Opin Neurol; 2000 Oct; 13(5):507-9. PubMed ID: 11073355
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins as a possible cause of inflammatory and necrotizing myopathies.
    Padala S; Thompson PD
    Atherosclerosis; 2012 May; 222(1):15-21. PubMed ID: 22154355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies.
    de Souza FHC; Miossi R; de Moraes JCB; Bonfá E; Shinjo SK
    Adv Rheumatol; 2018 Sep; 58(1):31. PubMed ID: 30657080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.